FMP

FMP

Enter

IMVT - Immunovant, Inc.

Valuation of Immunovant, Inc.(IMVT), Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the

Valuation Date:

Mar 27, 2024 3:00 PM

Share Price on Valuation Date

$32.52

Stock Beta

0.715

Shares Outstanding

145293000

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep